5 Hot Healthcare Stocks to Buy Now

3. Tilray Brands, Inc. (NASDAQ:TLRY)

Number of Hedge Fund Holders: 16    

YTD Perf: 20.45%

Avg Volume: 20.7M

Tilray Brands, Inc. (NASDAQ:TLRY) engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. On January 29, Tilray Brands, Inc. announced its financial results for the second quarter that ended on November 30, 2022. The firm appeared in robust financial standing with $433.5 million in cash and marketable securities. It also maintained the leadership position in Canada with 8.3% cannabis market share.

On January 10, 2023, MKM Partners analyst Bill Kirk maintained a Neutral rating on Tilray Brands, Inc. (NASDAQ:TLRY) stock and lowered the price target to $3 from $4.

At the end of the third quarter of 2022, 16 hedge funds in the database of Insider Monkey held stakes worth $33.6 million in Tilray Brands, Inc. (NASDAQ:TLRY), compared to 14 in the previous quarter worth $12.6 million.

Among the hedge funds being tracked by Insider Monkey, Greenwich, Connecticut-based investment firm Aristeia Capital is a leading shareholder in Tilray Brands, Inc. (NASDAQ:TLRY) with 23.6 million shares worth more than $23.3 million.